Bindhu V. Karanam
Drug Metabolism and Pharmacokinetics
Merck Research Laboratories
Rahway
NJ 07065
USA
Name/email consistency: high
- Metabolism and excretion of [14C]taranabant, a cannabinoid-1 inverse agonist, in humans. Karanam, B., Addy, C., Bateman, T., Reddy, V.B., Li, S., Dean, D., Li, H., Jones, A., Schenk, D., Zhang, A.S., Braun, M., Freeman, A., Flach, S., Stoch, A., Chodakewitz, J., Wagner, J.A., Kumar, S. Xenobiotica (2010)
- Absorption, metabolism, and excretion of [(14)C]MK-0524, a prostaglandin D(2) receptor antagonist, in humans. Karanam, B., Madeira, M., Bradley, S., Wenning, L., Desai, R., Soli, E., Schenk, D., Jones, A., Dean, B., Doss, G., Garrett, G., Crumley, T., Nirula, A., Lai, E. Drug Metab. Dispos. (2007)
- Effect of enalapril on the in vitro and in vivo peptidyl cleavage of a potent VLA-4 antagonist. Karanam, B.V., Jayraj, A., Rabe, M., Wang, Z., Keohane, C., Strauss, J., Vincent, S. Xenobiotica (2007)
- Species differential stereoselective oxidation of a methylsulfide metabolite of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor dual agonist. Karanam, B.V., Welch, C.J., Reddy, V.G., Chilenski, J., Biba, M., Vincent, S. Drug Metab. Dispos. (2004)
- In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterases. Karanam, B.V., Hop, C.E., Liu, D.Q., Wallace, M., Dean, D., Satoh, H., Komuro, M., Awano, K., Vincent, S.H. Drug Metab. Dispos. (2004)